PSMA7 and hematopoietic and lymphoid cell neoplasm: Indeed, in 2012, the results of a phase I/II clinical trial where 31 patients with hematologic cancers received transplants of two UCB units, one of which containing HSPC expanded ex vivo in a co-culture system with BM MSC, were published [13].